DISC MEDICINE INC. - COMMON STOCK

Disc Medicine Announces Collaboration with National Institutes of Health for Phase 2 Clinical Study of Bitopertin in Patients with Diamond-Blackfan Anemia (DBA)

21 3 2023 07:00:00 提供 Nasdaq GlobeNewswire

Disc Medicine Initiates a Phase 1b/2 Clinical Study of DISC-0974 in Adults with Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD) and Anemia

16 2 2023 08:00:56 提供 Nasdaq GlobeNewswire

Disc Medicine Announces $62.5 Million Financing led by Bain Capital Life Sciences to Advance Portfolio of Novel Hematology Programs

14 2 2023 06:30:00 提供 Nasdaq GlobeNewswire

Disc Medicine to Participate in SVB Securities Global Biopharma Conference

08 2 2023 16:00:00 提供 Nasdaq GlobeNewswire